{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:25:07Z","timestamp":1762521907687,"version":"3.37.3"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T00:00:00Z","timestamp":1467244800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12916-016-0642-2","type":"journal-article","created":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T18:52:10Z","timestamp":1467312730000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Fast and accurate dynamic estimation of field effectiveness of meningococcal vaccines"],"prefix":"10.1186","volume":"14","author":[{"given":"Lorenzo","family":"Argante","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Tizzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duccio","family":"Medini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,30]]},"reference":[{"issue":"40","key":"642_CR1","first-page":"331","volume":"77","author":"World Health Organization","year":"2002","unstructured":"World Health Organization. Meningococcal vaccines: polysaccharide and polysaccharide conjugate vaccines. Wkly Epidemiol Rec. 2002; 77(40):331\u20139.","journal-title":"Wkly Epidemiol Rec"},{"issue":"4","key":"642_CR2","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3201\/eid1904.111799","volume":"19","author":"OB Harrison","year":"2013","unstructured":"Harrison OB, Claus H, Jiang Y, Bennett JS, Bratcher HB, Jolley KA, et al.Description and nomenclature of Neisseria meningitidis capsule locus. Emerg Infect Dis. 2013; 19(4):566\u201373. doi: http:\/\/dx.doi.org\/10.3201\/eid1904.111799 .","journal-title":"Emerg Infect Dis"},{"issue":"1481\u20138531 (Elec","key":"642_CR3","first-page":"1","volume":"33","author":"Public Health Agency of Canada","year":"2007","unstructured":"Public Health Agency of Canada. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2004, through 31 December, 2005. Can Commun Dis Rep. 2007; 33(1481\u20138531 (Electronic)):1\u201315.","journal-title":"Can Commun Dis Rep"},{"issue":"6","key":"642_CR4","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3201\/eid1406.071357","volume":"14","author":"C Ines Agudelo","year":"2008","unstructured":"Ines Agudelo C, Sanabria OM, Ovalle MV. Serogroup Y meningococcal disease, Colombia. Emerg Infect Dis. 2008; 14(6):990\u20131. doi: http:\/\/dx.doi.org\/10.3201\/eid1406.071357 .","journal-title":"Emerg Infect Dis"},{"key":"642_CR5","first-page":"7","volume":"3","author":"FH Ciccone","year":"2006","unstructured":"Ciccone FH, Suzuki E, Pellini A. Meningococcal disease: communitarian outbreak investigation in Grajau, in the city of Sao Paulo. BEPA. 2006; 3:7\u201312.","journal-title":"BEPA"},{"issue":"1","key":"642_CR6","first-page":"21","volume":"39","author":"L Chiavetta","year":"2007","unstructured":"Chiavetta L, Chavez E, Ruzic A, Mollerach M, Regueira M. Surveillance of Neisseria meningitidis in Argentina, 1993\u20132005: distribution of serogroups, serotypes and serosubtypes isolated from invasive disease. Rev Argent Microbiol. 2007; 39(1):21\u20137.","journal-title":"Rev Argent Microbiol"},{"issue":"10","key":"642_CR7","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1128\/JCM.43.10.5129-5135.2005","volume":"43","author":"P Nicolas","year":"2005","unstructured":"Nicolas P, Norheim G, Garnotel E, Djibo S, Caugant DA. Molecular epidemiology of Neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes. J Clin Microbiol. 2005; 43(10):5129\u201335. doi: http:\/\/dx.doi.org\/10.1128\/JCM.43.10.5129-5135.2005 .","journal-title":"J Clin Microbiol"},{"issue":"2","key":"642_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3201\/eid1302.051553","volume":"13","author":"GB Coulson","year":"2007","unstructured":"Coulson GB, von Gottberg A, du Plessis M, Smith AM, de Gouveia L, Klugman KP. Meningococcal disease in South Africa, 1999\u20132002. Emerg Infect Dis. 2007; 13(2):273\u201381. doi: http:\/\/dx.doi.org\/10.3201\/eid1302.051553 .","journal-title":"Emerg Infect Dis"},{"key":"642_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2334-6-25","volume":"6","author":"CS Chiou","year":"2006","unstructured":"Chiou CS, Liao JC, Liao TL, Li CC, Chou CY, Chang HL, et al.Molecular epidemiology and emergence of worldwide epidemic clones of Neisseria meningitidis in Taiwan. BMC Infect Dis. 2006; 6:25. doi: http:\/\/dx.doi.org\/10.1186\/1471-2334-6-25 .","journal-title":"BMC Infect Dis"},{"issue":"0022\u20132615","key":"642_CR10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1099\/jmm.0.45541-0","volume":"53","author":"H Takahashi","year":"2004","unstructured":"Takahashi H, Kuroki T, Watanabe Y, Tanaka H, Inouye H, Yamai S, et al.Characterization of Neisseria meningitidis isolates collected from 1974 to 2003 in Japan by multilocus sequence typing. J Med Microbiol. 2004; 53(0022\u20132615):657\u201362. doi: http:\/\/dx.doi.org\/10.1099\/jmm.0.45541-0 .","journal-title":"J Med Microbiol"},{"issue":"3","key":"642_CR11","first-page":"347","volume":"39","author":"N Lara","year":"2015","unstructured":"Australian Gonococcal Surveillance Programme, Lara N. Annual report of the Australian gonococcal surveillance programme, 2014. Commun Dis Intell Q Rep. 2015; 39(3):347\u201354.","journal-title":"Commun Dis Intell Q Rep"},{"issue":"123","key":"642_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1126\/scitranslmed.3003859","volume":"4","author":"S Black","year":"2012","unstructured":"Black S, Pizza M, Nissum M, Rappuoli R. Toward a meningitis-free world. Sci Trans Med. 2012; 4(123):123\u20135. doi: http:\/\/dx.doi.org\/10.1126\/scitranslmed.3003859 .","journal-title":"Sci Trans Med"},{"key":"642_CR13","unstructured":"Centers for Disease Control and Prevention. Meningococcal disease In: Hamborsky J, Kroger A, Wolfe S, editors. Epidemiology and prevention of vaccine-preventable diseases. Vol. 39. 13th ed: 1993. p. 3\u201325. Chap. 14. http:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/downloads\/mening.pdf ."},{"issue":"9508","key":"642_CR14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(06)67932-4","volume":"367","author":"MJ Thompson","year":"2006","unstructured":"Thompson MJ, Ninis N, Perera R, Mayon-White R, Phillips C, Bailey L, et al.Clinical recognition of meningococcal disease in children and adolescents. Lancet. 2006; 367(9508):397\u2013403. doi: http:\/\/dx.doi.org\/10.1016\/S0140-6736(06)67932-4 .","journal-title":"Lancet"},{"issue":"18","key":"642_CR15","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","volume":"344","author":"NE Rosenstein","year":"2001","unstructured":"Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. Meningococcal disease. N Engl J Med. 2001; 344(18):1378\u201388. doi: http:\/\/dx.doi.org\/10.1056\/NEJM200105033441807 .","journal-title":"N Engl J Med"},{"key":"642_CR16","unstructured":"European Centre for Disease Prevention and Control. Surveillance of invasive bacterial diseases in Europe 2012. 2015:89. doi: http:\/\/dx.doi.org\/10.2900\/1510 . http:\/\/www.worldcat.org\/title\/surveillance-of-invasive-bacterial-diseases-in-europe-20082009\/oclc\/759934800 ."},{"key":"642_CR17","unstructured":"WHO. Meningococcal meningitis fact sheet. 2015. http:\/\/www.who.int\/mediacentre\/factsheets\/fs141\/en\/ . Accessed 11 Nov 2015."},{"issue":"3","key":"642_CR18","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1017\/S0950268805005339","volume":"134","author":"CL Trotter","year":"2006","unstructured":"Trotter CL, Gay NJ, Edmunds WJ. The natural history of meningococcal carriage and disease. Epidemiol Infect. 2006; 134(3):556\u201366. doi: http:\/\/dx.doi.org\/10.1017\/S0950268805005339 .","journal-title":"Epidemiol Infect"},{"issue":"12","key":"642_CR19","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S1473-3099(10)70251-6","volume":"10","author":"H Christensen","year":"2010","unstructured":"Christensen H, May M, Bowen L, Hickman M, Trotter CL. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis. 2010; 10(12):853\u201361. doi: http:\/\/dx.doi.org\/10.1016\/S1473-3099(10)70251-6 .","journal-title":"Lancet Infect Dis"},{"issue":"16","key":"642_CR20","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1056\/NEJMra0906357","volume":"362","author":"LKK Tan","year":"2010","unstructured":"Tan LKK, Carlone GM, Borrow R. Advances in the development of vaccines against Neisseria meningitidis. N Engl J Med. 2010; 362(16):1511\u201320. doi: http:\/\/dx.doi.org\/10.1016\/S0084-3873(10)79653-X .","journal-title":"N Engl J Med"},{"issue":"9251","key":"642_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0140-6736(00)03594-7","volume":"357","author":"ME Ramsay","year":"2001","unstructured":"Ramsay ME, Andrews N, Kaczmarski EB, Miller E. Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet. 2001; 357(9251):195\u20136. doi: http:\/\/dx.doi.org\/10.1016\/S0140-6736(00)03594-7 .","journal-title":"Lancet"},{"issue":"10","key":"642_CR22","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/0264-410X(92)90091-W","volume":"10","author":"P Costantino","year":"1992","unstructured":"Costantino P, Viti S, Podda A, Velmonte MA, Nencioni L, Rappuoli R. Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C. Vaccine. 1992; 10(10):691\u20138. doi: http:\/\/dx.doi.org\/10.1016\/0264-410X(92)90091-W .","journal-title":"Vaccine"},{"issue":"1","key":"642_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1473-3099(04)01251-4","volume":"5","author":"MD Snape","year":"2005","unstructured":"Snape MD, Pollard AJ. Meningococcal polysaccharide\u2013protein conjugate vaccines. Lancet Infect Dis. 2005; 5(1):21\u201330. doi: http:\/\/dx.doi.org\/10.1016\/S1473-3099(04)01251-4 .","journal-title":"Lancet Infect Dis"},{"issue":"9358","key":"642_CR24","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0140-6736(03)12563-9","volume":"361","author":"A Bose","year":"2003","unstructured":"Bose A, Coen P, Tully J, Viner R, Booy R. Effectiveness of meningococcal C conjugate vaccine in teenagers in England. Lancet. 2003; 361(9358):675\u20136. doi: http:\/\/dx.doi.org\/10.1016\/S0140-6736(03)12563-9 .","journal-title":"Lancet"},{"issue":"9431","key":"642_CR25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","volume":"364","author":"CL Trotter","year":"2004","unstructured":"Trotter CL, Andrews NJ, Kaczmarski EB, Miller E, Ramsay ME. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet. 2004; 364(9431):365\u20137. doi: http:\/\/dx.doi.org\/10.1016\/S0140-6736(04)16725-1 .","journal-title":"Lancet"},{"issue":"5","key":"642_CR26","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1128\/CVI.00529-09","volume":"17","author":"H Campbell","year":"2010","unstructured":"Campbell H, Andrews N, Borrow R, Trotter C, Miller E. Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity. Clin Vaccine Immunol. 2010; 17(5):840\u20137. doi: http:\/\/dx.doi.org\/10.1128\/CVI.00529-09 .","journal-title":"Clin Vaccine Immunol"},{"issue":"41","key":"642_CR27","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1016\/j.vaccine.2013.07.083","volume":"31","author":"R Borrow","year":"2013","unstructured":"Borrow R, Abad R, Trotter C, van der Klis FRM, Vazquez JA. Effectiveness of meningococcal serogroup C vaccine programmes. Vaccine. 2013; 31(41):4477\u201386. doi: http:\/\/dx.doi.org\/10.1016\/j.vaccine.2013.07.083 .","journal-title":"Vaccine"},{"issue":"9320","key":"642_CR28","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/S0140-6736(02)08679-8","volume":"359","author":"MC Maiden","year":"2002","unstructured":"Maiden MC, Stuart JM. Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet. 2002; 359(9320):1829\u201330. doi: http:\/\/dx.doi.org\/10.1016\/S0140-6736(02)08679-8 .","journal-title":"Lancet"},{"issue":"7385","key":"642_CR29","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/bmj.326.7385.365","volume":"326","author":"ME Ramsay","year":"2003","unstructured":"Ramsay ME. Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis. BMJ. 2003; 326(7385):365\u20136. doi: http:\/\/dx.doi.org\/10.1136\/bmj.326.7385.365 .","journal-title":"BMJ"},{"issue":"5","key":"642_CR30","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1086\/527401","volume":"197","author":"MCJ Maiden","year":"2008","unstructured":"Maiden MCJ, Ibarz-Pav\u00f3n AB, Urwin R, Gray SJ, Andrews NJ, Clarke SC, et al.Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J Infect Dis. 2008; 197(5):737\u201343. doi: http:\/\/dx.doi.org\/10.1086\/527401 .","journal-title":"J Infect Dis"},{"issue":"7","key":"642_CR31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1179\/2047773214Y.0000000162","volume":"108","author":"G Vernikos","year":"2014","unstructured":"Vernikos G, Medini D. Bexsero\u00ae; chronicle. Pathogens Global Health. 2014; 108(7):305\u201316. doi: http:\/\/dx.doi.org\/10.1179\/2047773214Y.0000000162 .","journal-title":"Pathogens Global Health"},{"issue":"45","key":"642_CR32","doi-asserted-by":"publisher","first-page":"19490","DOI":"10.1073\/pnas.1013758107","volume":"107","author":"J Donnelly","year":"2010","unstructured":"Donnelly J, Medini D, Boccadifuoco G, Biolchi A, Ward J, Frasch C, et al.Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines. Proc Nat Acad Sci. 2010; 107(45):19490\u20135. doi: http:\/\/dx.doi.org\/10.1073\/pnas.1013758107 .","journal-title":"Proc Nat Acad Sci"},{"issue":"5","key":"642_CR33","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S1473-3099(13)70006-9","volume":"13","author":"U Vogel","year":"2013","unstructured":"Vogel U, Taha MK, Vazquez JA, Findlow J, Claus H, Stefanelli P, et al.Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. Lancet Infect Dis. 2013; 13(5):416\u201325. doi: http:\/\/dx.doi.org\/10.1016\/S1473-3099(13)70006-9 .","journal-title":"Lancet Infect Dis"},{"key":"642_CR34","doi-asserted-by":"crossref","unstructured":"Halloran ME, Longini Jr IM, Struchiner CJ. Design and analysis of vaccine studies: introduction. Springer-Verlag New York: Stat Biol Health: 2009. doi: http:\/\/dx.doi.org\/10.1007\/978-0-387-68636-3 .","DOI":"10.1007\/978-0-387-68636-3"},{"issue":"4","key":"642_CR35","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/ije\/22.4.742","volume":"22","author":"CP Farrington","year":"1993","unstructured":"Farrington CP. Estimation of vaccine effectiveness using the screening method. Int J Epidemiol. 1993; 22(4):742\u20136. doi: http:\/\/dx.doi.org\/10.1093\/ije\/22.4.742 .","journal-title":"Int J Epidemiol"},{"issue":"6","key":"642_CR36","first-page":"1055","volume":"63","author":"WA Orenstein","year":"1985","unstructured":"Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, Bart KJ, et al.Field evaluation of vaccine efficacy. Bull World Health Org. 1985; 63(6):1055\u201368.","journal-title":"Bull World Health Org"},{"issue":"8","key":"642_CR37","doi-asserted-by":"publisher","first-page":"41785","DOI":"10.1371\/journal.pone.0041785","volume":"7","author":"AL Cohen","year":"2012","unstructured":"Cohen AL, Taylor T, Farley MM, Schaffner W, Lesher LJ, Gershman KA, et al.An assessment of the screening method to evaluate vaccine effectiveness: the case of 7-valent pneumococcal conjugate vaccine in the United States. PloS One. 2012; 7(8):41785. doi: http:\/\/dx.doi.org\/10.1371\/journal.pone.0041785 .","journal-title":"PloS One"},{"issue":"8","key":"642_CR38","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1586\/14760584.2014.930666","volume":"13","author":"L Minodier","year":"2014","unstructured":"Minodier L, Blanchon T, Souty C, Turbelin C, Leccia F, Varesi L, et al.Influenza vaccine effectiveness: best practice and current limitations of the screening method and their implications for the clinic. Expert Rev Vacc. 2014; 13(8):1039\u201348. doi: http:\/\/dx.doi.org\/10.1586\/14760584.2014.930666 .","journal-title":"Expert Rev Vacc"},{"key":"642_CR39","unstructured":"Public Health England. Meningococcal disease: laboratory confirmed cases in England and Wales. https:\/\/www.gov.uk\/government\/publications . Accessed 11 Nov 2015."},{"issue":"1","key":"642_CR40","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/0272989X05284109","volume":"26","author":"CL Trotter","year":"2006","unstructured":"Trotter CL, Edmunds WJ. Reassessing the cost-effectiveness of meningococcal serogroup C conjugate (MCC) vaccines using a transmission dynamic model. Med Decis Mak: Int J Soc Med Decis Mak. 2006; 26(1):38\u201347. doi: http:\/\/dx.doi.org\/10.1177\/0272989X05284109 .","journal-title":"Med Decis Mak: Int J Soc Med Decis Mak."},{"issue":"1","key":"642_CR41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/aje\/kwi160","volume":"162","author":"CL Trotter","year":"2005","unstructured":"Trotter CL. Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination. Am J Epidemiol. 2005; 162(1):89\u2013100. doi: http:\/\/dx.doi.org\/10.1093\/aje\/kwi160 .","journal-title":"Am J Epidemiol"},{"issue":"25\u201326","key":"642_CR42","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1016\/j.vaccine.2009.01.092","volume":"27","author":"G Guzzetta","year":"2009","unstructured":"Guzzetta G, Manfredi P, Gasparini R, Panatto D, Edmunds WJ. On the relationship between meningococcal transmission dynamics and disease: remarks on humoral immunity. Vaccine. 2009; 27(25\u201326):3429\u201334. doi: http:\/\/dx.doi.org\/10.1016\/j.vaccine.2009.01.092 .","journal-title":"Vaccine"},{"issue":"23","key":"642_CR43","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1016\/j.vaccine.2013.03.034","volume":"31","author":"H Christensen","year":"2013","unstructured":"Christensen H, Hickman M, Edmunds WJ, Trotter CL. Introducing vaccination against serogroup B meningococcal disease: an economic and mathematical modelling study of potential impact. Vaccine. 2013; 31(23):2638\u201346. doi: http:\/\/dx.doi.org\/10.1016\/j.vaccine.2013.03.034 .","journal-title":"Vaccine"},{"issue":"2","key":"642_CR44","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1109\/78.978374","volume":"50","author":"MS Arulampalam","year":"2002","unstructured":"Arulampalam MS, Maskell S, Gordon N, Clapp T. A tutorial on particle filters for online nonlinear\/non-Gaussian Bayesian tracking. IEEE Trans Signal Process. 2002; 50(2):174\u201388. doi: http:\/\/dx.doi.org\/10.1109\/78.978374 .","journal-title":"IEEE Trans Signal Process"},{"key":"642_CR45","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.vaccine.2009.04.061","volume":"27","author":"DA Caugant","year":"2009","unstructured":"Caugant DA, Maiden MCJ. Meningococcal carriage and disease \u2013 population biology and evolution. Vaccine. 2009; 27:64\u201370. doi: http:\/\/dx.doi.org\/10.1016\/j.vaccine.2009.04.061 .","journal-title":"Vaccine"},{"key":"642_CR46","volume-title":"Handbook of meningococcal disease management","author":"R \u00d8vsteb\u00f8","year":"2016","unstructured":"\u00d8vsteb\u00f8 R, Hellerud BC, Coureuil M, Nassif X, Brandtzaeg P. Pathogenesis of invasive disease In: Feavers I, Pollard AJ, Sadarangani M, editors. Handbook of meningococcal disease management. Switzerland: Springer International Publishing: 2016. p. 25\u201343. Chap. 3. doi: http:\/\/dx.doi.org\/10.1007\/978-3-319-28119-3 ."},{"key":"642_CR47","unstructured":"Office of National Statistics. Population. http:\/\/ons.gov.uk\/ons\/taxonomy\/index.html?nscl=Population . Accessed 11 Nov 2015."},{"issue":"3","key":"642_CR48","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1371\/journal.pmed.0050074","volume":"5","author":"J Mossong","year":"2008","unstructured":"Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, et al.Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008; 5(3):74. doi: http:\/\/dx.doi.org\/10.1371\/journal.pmed.0050074 .","journal-title":"PLoS Med"},{"issue":"4","key":"642_CR49","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1093\/ije\/14.4.628","volume":"14","author":"P De Wals","year":"1985","unstructured":"De Wals P, Bouckaert A. Methods for estimating the duration of bacterial carriage. Int J Epidemiol. 1985; 14(4):628\u201334. doi: http:\/\/dx.doi.org\/10.1093\/ije\/14.4.628 .","journal-title":"Int J Epidemiol"},{"issue":"12","key":"642_CR50","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.trstmh.2006.01.004","volume":"100","author":"DA Caugant","year":"2006","unstructured":"Caugant DA, Fogg C, Bajunirwe F, Piola P, Twesigye R, Mutebi F, et al.Pharyngeal carriage of Neisseria meningitidis in 2\u201319-year-old individuals in Uganda. Trans R Soc Trop Med Hyg. 2006; 100(12):1159\u201363. doi: http:\/\/dx.doi.org\/10.1016\/j.trstmh.2006.01.004 .","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3\u20134","key":"642_CR51","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ijheh.2007.05.006","volume":"211","author":"IC Glitza","year":"2008","unstructured":"Glitza IC, Ehrhard I, M\u00fcller-Pebody B, Reintjes R, Breuer T, Ammon A, et al.Longitudinal study of meningococcal carrier rates in teenagers. Int J Hygiene Environ Health. 2008; 211(3\u20134):263\u201372. doi: http:\/\/dx.doi.org\/10.1016\/j.ijheh.2007.05.006 .","journal-title":"Int J Hygiene Environ Health"},{"issue":"3","key":"642_CR52","first-page":"220","volume":"5","author":"CL Trotter","year":"2002","unstructured":"Trotter CL, Ramsay ME, Kaczmarski EB. Meningococcal serogroup C conjugate vaccination in England and Wales: coverage and initial impact of the campaign. Commun Dis Public Health\/PHLS. 2002; 5(3):220\u20135.","journal-title":"Commun Dis Public Health\/PHLS"},{"issue":"March","key":"642_CR53","first-page":"2327","volume":"348","author":"J Wise","year":"2014","unstructured":"Wise J. Meningitis B vaccine to be introduced in UK after U turn on its cost effectiveness. BMJ (Clinical research ed.) 2014; 348(March):2327. doi: http:\/\/dx.doi.org\/10.1136\/bmj.g2327 .","journal-title":"BMJ (Clinical research ed.)"},{"key":"642_CR54","unstructured":"Public Health England. National childhood immunisation programme boosted by MenB vaccine. 2015. https:\/\/www.gov.uk\/government\/news\/national-childhood-immunisation-programme-boosted-by-menb-vaccine . Accessed 11 Nov 2015."},{"issue":"5","key":"642_CR55","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S1473-3099(13)70341-4","volume":"14","author":"SM Andrews","year":"2014","unstructured":"Andrews SM, Pollard AJ. A vaccine against serogroup B Neisseria meningitidis: dealing with uncertainty. Lancet Infect Dis. 2014; 14(5):426\u201334. doi: http:\/\/dx.doi.org\/10.1016\/S1473-3099(13)70341-4 .","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"642_CR56","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1179\/2047773213Y.0000000119","volume":"107","author":"A Abio","year":"2013","unstructured":"Abio A, Neal KR, Beck CR. An epidemiological review of changes in meningococcal biology during the last 100 years. Pathogens Global Health. 2013; 107(7):373\u201380. doi: http:\/\/dx.doi.org\/10.1179\/2047773213Y.0000000119 .","journal-title":"Pathogens Global Health"},{"key":"642_CR57","volume-title":"Handbook of meningococcal disease management","author":"C Trotter","year":"2016","unstructured":"Trotter C, Ramsay M, Harrison L. Introduction and epidemiology of meningococcal disease In: Feavers I, Pollard AJ, Sadarangani M, editors. Handbook of meningococcal disease management. Switzerland: Springer International Publishing: 2016. p. 1\u201314. Chap. 1. doi: http:\/\/dx.doi.org\/10.1007\/978-3-319-28119-3 ."},{"issue":"49","key":"642_CR58","doi-asserted-by":"publisher","first-page":"18438","DOI":"10.1073\/pnas.0603181103","volume":"103","author":"EL Ionides","year":"2006","unstructured":"Ionides EL, Breto C, King AA. Inference for nonlinear dynamical systems. Proc Nat Acad Sci. 2006; 103(49):18438\u201343. doi: http:\/\/dx.doi.org\/10.1073\/pnas.0603181103 .","journal-title":"Proc Nat Acad Sci"},{"issue":"7206","key":"642_CR59","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/nature07084","volume":"454","author":"AA King","year":"2008","unstructured":"King AA, Ionides EL, Pascual M, Bouma MJ. Inapparent infections and cholera dynamics. Nature. 2008; 454(7206):877\u201380. doi: http:\/\/dx.doi.org\/10.1038\/nature07084 .","journal-title":"Nature"},{"issue":"1725","key":"642_CR60","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1098\/rspb.2011.0300","volume":"278","author":"A Camacho","year":"2011","unstructured":"Camacho A, Ballesteros S, Graham AL, Carrat F, Ratmann O, Cazelles B. Explaining rapid reinfections in multiple-wave influenza outbreaks: Tristan da Cunha 1971 epidemic as a case study. Proc R Soc B: Biol Sci. 2011; 278(1725):3635\u201343. doi: http:\/\/dx.doi.org\/10.1098\/rspb.2011.0300 .","journal-title":"Proc R Soc B: Biol Sci"},{"issue":"191","key":"642_CR61","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/scitranslmed.3005982","volume":"5","author":"S Shrestha","year":"2013","unstructured":"Shrestha S, Foxman B, Weinberger DM, Steiner C, Viboud C, Rohani P. Identifying the interaction between influenza and pneumococcal pneumonia using incidence data. Sci Trans Med. 2013; 5(191):84. doi: http:\/\/dx.doi.org\/10.1126\/scitranslmed.3005982 .","journal-title":"Sci Trans Med"},{"key":"642_CR62","doi-asserted-by":"publisher","first-page":"5725","DOI":"10.1136\/bmj.g5725","volume":"349","author":"H Christensen","year":"2014","unstructured":"Christensen H, Trotter CL, Hickman M, Edmunds WJ. Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study. BMJ. 2014; 349:5725. doi: http:\/\/dx.doi.org\/10.1136\/bmj.g5725 .","journal-title":"BMJ"},{"issue":"Pt 7","key":"642_CR63","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1099\/jmm.0.46288-0","volume":"55","author":"SJ Gray","year":"2006","unstructured":"Gray SJ, Trotter CL, Ramsay ME, Guiver M, Fox AJ, Borrow R, et al.Epidemiology of meningococcal disease in England and Wales 1993\/94 to 2003\/04: contribution and experiences of the Meningococcal Reference Unit. J Med Microbiol. 2006; 55(Pt 7):887\u201396. doi: http:\/\/dx.doi.org\/10.1099\/jmm.0.46288-0 .","journal-title":"J Med Microbiol"},{"issue":"1","key":"642_CR64","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/1741-7015-10-165","volume":"10","author":"M Tizzoni","year":"2012","unstructured":"Tizzoni M, Bajardi P, Poletto C, Ramasco JJ, Balcan D, Gon\u00e7alves B, et al.Real-time numerical forecast of global epidemic spreading: case study of 2009 A\/H1N1pdm. BMC Med. 2012; 10(1):165. doi: http:\/\/dx.doi.org\/10.1186\/1741-7015-10-165 .","journal-title":"BMC Med"},{"issue":"1","key":"642_CR65","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jinf.2015.02.006","volume":"71","author":"CA Jeppesen","year":"2015","unstructured":"Jeppesen CA, Snape MD, Robinson H, Gossger N, John TM, Voysey M, et al.Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy. J Infect. 2015; 71(1):43\u201352. doi: http:\/\/dx.doi.org\/10.1016\/j.jinf.2015.02.006 .","journal-title":"J Infect"},{"key":"642_CR66","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12879-015-1015-8","volume":"15","author":"KD Poore","year":"2015","unstructured":"Poore KD, Bauch CT. The impact of aggregating serogroups in dynamic models of Neisseria meningitidis transmission. BMC Infect Dis. 2015; 15:300. doi: http:\/\/dx.doi.org\/10.1186\/s12879-015-1015-8 .","journal-title":"BMC Infect Dis"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-016-0642-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-016-0642-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-016-0642-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-016-0642-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T13:33:34Z","timestamp":1498311214000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-016-0642-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,30]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["642"],"URL":"https:\/\/doi.org\/10.1186\/s12916-016-0642-2","relation":{},"ISSN":["1741-7015"],"issn-type":[{"type":"electronic","value":"1741-7015"}],"subject":[],"published":{"date-parts":[[2016,6,30]]},"article-number":"98"}}